Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
At Set Point Medical Weight Loss Clinic, we prioritize your safety and well-being
For example, symptoms blamed on low energy may actually relate to anemia, thyroid disease, sleep problems, depression, infection, or cardiovascular disease
do not obtain retatrutide from online pharmacies, compounding services, or any unregulated source On the day of your injection: Eat a light, low-fat meal beforehand rather than a large or greasy one, as this may worsen nausea Inject at a time of day that suits your schedule many people prefer mornings so that any early reactions can be monitored while awake Rotate injection sites to reduce localised skin reactions Remain well hydrated throughout the day Sharps safety: Dispose of used needles and syringes immediately in the sharps bin provided by your trial team Never share needles, syringes, or injection pens with anyone else Follow your local NHS arrangements for the collection or disposal of full sharps bins Ongoing safety considerations: Do not adjust your dose without medical guidance If you are taking insulin or other glucose-lowering agents, your clinician may need to review and adjust these to reduce the risk of hypoglycaemia Limit alcohol, particularly in the early weeks of treatment, as it may worsen nausea and dizziness If you experience significant vomiting or diarrhoea, discuss 'sick day rules' for any other medicines you take (for example, certain blood pressure or diabetes medications) with your clinical team Keep a written or digital log of any symptoms to share with your healthcare team at your next appointment In line with NICE guidance on shared decision-making, your healthcare team should have discussed the potential benefits, risks, and alternatives with you before commencing treatment
Efficacy of DSIP to normalize sleep in middle-aged and elderly insomniacs
2025: A retrospective study among 25 adults requiring carnitine replacement therapy showed that those on famotidine were much more likely to have low carnitine levels despite supplementation compared to those not taking famotidine (36.8% vs
